Long-Term Inducible Gene Expression in the Eye via Adeno-Associated Virus Gene Transfer in Nonhuman Primates
- 1 February 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 16 (2) , 178-186
- https://doi.org/10.1089/hum.2005.16.178
Abstract
Adeno-associated viral gene therapy has shown promise for the treatment of inherited and degenerative diseases in a variety of animal models. Some of the most dramatic results have been obtained in the field of ocular gene therapy, where efficacy has been tremendous in inherited and acquired retinal disorders. For the promise of this approach to be realized it will be necessary to create vectors capable of pharmacologic or physiologic regulation of the transgene. We describe in this paper a dimerizer–inducible viral expression system that is able to reproducibly drive expression of the reporter gene erythropoietin in the eyes of nonhuman primates over a period of 2.5 years. The expression profiles were characterized by minimal basal expression in the absence of inducer and dose-responsive maximal expression in the presence of inducer drug.Keywords
This publication has 16 references indexed in Scilit:
- Immune Responses to Recombinant Adeno-Associated Virus Vectors: Putting Preclinical Findings into PerspectiveHuman Gene Therapy, 2004
- Autoimmune anemia in macaques following erythropoietin gene therapyBlood, 2004
- Erythropoietin gene therapy leads to autoimmune anemia in macaquesBlood, 2004
- From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene TherapyCurrent Gene Therapy, 2003
- An in vivo doxycycline-controlled expression system for functional studies of the retina.Investigative Opthalmology & Visual Science, 2003
- Sustained tetracycline‐regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno‐associated viral vectorThe Journal of Gene Medicine, 2003
- Erythropoietin and VEGF Exhibit Equal Angiogenic PotentialMicrovascular Research, 2002
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Pharmacological Regulation of Protein Expression from Adeno-Associated Viral Vectors in the EyeMolecular Therapy, 2002
- Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaProceedings of the National Academy of Sciences, 1999